TY  - JOUR
AU  - Maroto, P
AU  - Esteban, E
AU  - Parra, E Fernández
AU  - Mendez-Vidal, M J
AU  - Domenech, M
AU  - Pérez-Valderrama, B
AU  - Calderero, V
AU  - Pérez-Gracia, J L
AU  - Grande, E
AU  - Algaba, F
PY  - 2017
DO  - 10.2147/OTT.S137677
SN  - 1178-6930
UR  - http://hdl.handle.net/10668/11685
T2  - OncoTargets and therapy
AB  - Clear-cell renal cell carcinoma (ccRCC) is a heterogeneous disease with a different clinical behavior and response to targeted therapies. Differences in hypoxia-inducible factor (HIF) expression have been used to classify von Hippel-Lindau gene...
LA  - en
KW  - HIF
KW  - c-Myc
KW  - clear-cell renal cell carcinoma
KW  - sunitinib
TI  - HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma.
TY  - research article
VL  - 10
ER  -